PBMs: Raising Drug Prices for Seniors… Pocketing “Rebates” for Themselves.

Infographic
Click Here.

LTC Pharmacy Advocacy Group Praises Sen. Alexander, HELP Committee Focus on Drug Pricing

In praising Senate Health, Education, Pension and Labor (HELP) Chairman Lamar Alexander (R-TN) and Committee members for initiating a key discussion on the rising cost of prescription drugs, the Senior Care Pharmacy Coalition (SCPC) today urged Congress to prioritize focus not just on the entire drug supply chain…Read More

PBMs Continue to Lose Health Policy Debate Surrounding Rising Costs, Pricing Transparency

The Senior Care Pharmacy Coalition (SCPC) today said Pharmacy Benefit Managers (PBMS) continue to lose ground surrounding the public debate on culpability for rising drug prices, and the need for significantly more drug pricing transparency along the nation’s pharmaceutical supply chain…Read More

SCPC Praises Sen. Lamar Alexander’s Announcement on Senate Drug Pricing Hearing

The Senior Care Pharmacy Coalition (SCPC) today welcomed this week’s announcement by Senate Health, Education, Pension and Labor (HELP) Chairman Lamar Alexander (R-TN) that the Committee will soon hold a hearing on a range of issues surrounding drug pricing…Read More

Today’s PCMA PBM “Policy Forum”: A Parallel Universe of Propaganda and Puffery

With the Pharmaceutical Care Management Association (PCMA) today holding its 2017 “PBM Policy Forum” at the Newseum, the Senior Care Pharmacy Coalition (SCPC) said the gathering and its discussion is yet another attempt to divert attention away…Read More

As Congress Reconvenes, PBM Middlemen Remain on Defense as Questionable Practices, Bipartisan Transparency Legislation Drive Drug Pricing Discussion

As Congress reconvenes this week, the increasingly controversial role of Pharmacy Benefit Managers (PBMs) in the national drug pricing chain are again in the spotlight as bipartisan, bicameral bills to limit opaque PBM pricing practices drive the drug pricing discussion…Read More

National, Georgia LTC Pharmacy Leaders Praise U.S. Reps. Doug Collins, Buddy Carter Leadership in Taking on Unaccountable Pharmacy Benefit Manager (PBM) Drug Pricing Middlemen

As escalating drug prices have increasingly roiled consumers throughout Georgia, national and state Long Term Care (LTC) pharmacy leaders today praised the vigorous, persistent and effective efforts of U.S. Reps. Doug Collins (R-GA) and Buddy Carter (R-GA) in taking on the increasingly controversial Pharmacy Benefit Manager (PBM) middlemen…Read More

Wyden “C-Thru” Bill Helps Pull Back Curtain on Duplicitous PBM “Rebates,” Suspect Pricing Schemes, Related Anti-Competitive Behavior

Noting a torrent of bipartisan legislation recently introduced requiring Pharmacy Benefit Manager (PBM) drug middlemen to pull back the curtain on veiled, opaque pharmaceutical pricing practices, the Senior Care Pharmacy Coalition (SCPC) today backed Sen. Ron Wyden’s (D-OR) “Creating Transparency to Have Drug Rebates Unlocked Act” (C-THRU) bill…Read More

SCPC Looks Forward to Working with CMS Administrator Seema Verma to Hold PBMs Accountable for Opaque, Controversial Drug Pricing Practices

Following U.S. Senate confirmation of Seema Verma as the new Administrator of the Centers for Medicare and Medicaid Services (CMS), the Senior Care Pharmacy Coalition (SCPC) praised her approval and said the Long-Term Care (LTC) Pharmacy advocacy group looks forward to working with her to hold Pharmacy Benefit Managers (PBMs) more accountable for the opaque, controversial pricing practices that have spurred Congress to propose multiple legislative remedies to do so…Read More

SCPC Praises Collins/Loebsack Bill Boosting Generic Prescription Drug Payment Transparency

In praising U.S. Reps. Doug Collins (R-GA) and Dave Loebsack (D-IA) for introducing the Prescription Drug Price Transparency Act (H.R. 1316), Senior Care Pharmacy Coalition (SCPC) President and CEO Alan G. Rosenbloom observed that the nation’s drug pricing middlemen — Pharmacy Benefit Managers (PBMs) — are rightly facing a growing barrage of criticism from a widening group of bipartisan lawmakers demanding answers about rising prescription drug prices, and the practices driving increases……Read More

Twitter   LinkedIn